SG45292G - Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride - Google Patents

Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride

Info

Publication number
SG45292G
SG45292G SG45292A SG45292A SG45292G SG 45292 G SG45292 G SG 45292G SG 45292 A SG45292 A SG 45292A SG 45292 A SG45292 A SG 45292A SG 45292 G SG45292 G SG 45292G
Authority
SG
Singapore
Prior art keywords
hydroxyethylamino
dihydrochloride
anthraquinone
dihydroxy
bis
Prior art date
Application number
SG45292A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG45292G publication Critical patent/SG45292G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
SG45292A 1986-03-07 1992-04-24 Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride SG45292G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07

Publications (1)

Publication Number Publication Date
SG45292G true SG45292G (en) 1992-06-12

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
SG45292A SG45292G (en) 1986-03-07 1992-04-24 Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride

Country Status (21)

Country Link
EP (1) EP0236822B1 (fr)
JP (1) JPH0717500B2 (fr)
KR (1) KR900002030B1 (fr)
AT (1) ATE59290T1 (fr)
AU (1) AU593330B2 (fr)
CA (1) CA1283607C (fr)
DE (1) DE3766984D1 (fr)
DK (1) DK166754B1 (fr)
ES (1) ES2033247T3 (fr)
FI (1) FI84977C (fr)
GR (1) GR3001503T3 (fr)
HK (1) HK63991A (fr)
HU (1) HU199286B (fr)
IE (1) IE60025B1 (fr)
IL (1) IL81681A (fr)
NO (1) NO173635C (fr)
NZ (1) NZ219454A (fr)
PH (1) PH22808A (fr)
PT (1) PT84398B (fr)
SG (1) SG45292G (fr)
ZA (1) ZA871652B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
ES2627409T3 (es) * 2010-12-09 2017-07-28 Maruishi Pharmaceutical Co., Ltd. Estabilizador del acetaminofeno
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
EP0154117B1 (fr) * 1984-02-27 1989-12-27 American Cyanamid Company Utilisation des anthrachinones 1,4 bi-substitueés pour la fabrication des medicaments immunosuppresives

Also Published As

Publication number Publication date
PT84398A (en) 1987-04-01
NO870950D0 (no) 1987-03-06
DK166754B1 (da) 1993-07-12
IL81681A0 (en) 1987-09-16
HU199286B (en) 1990-02-28
CA1283607C (fr) 1991-04-30
GR3001503T3 (en) 1992-11-23
KR900002030B1 (ko) 1990-03-31
DK116687D0 (da) 1987-03-06
FI84977C (fi) 1992-02-25
AU593330B2 (en) 1990-02-08
NO870950L (no) 1987-09-08
EP0236822B1 (fr) 1990-12-27
AU6977387A (en) 1987-09-10
ES2033247T3 (es) 1993-03-16
ATE59290T1 (de) 1991-01-15
DK116687A (da) 1987-09-08
EP0236822A2 (fr) 1987-09-16
NO173635B (no) 1993-10-04
IL81681A (en) 1991-01-31
IE60025B1 (en) 1994-05-18
FI84977B (fi) 1991-11-15
PH22808A (en) 1988-12-27
FI870994A0 (fi) 1987-03-06
FI870994A (fi) 1987-09-08
ZA871652B (en) 1987-08-28
JPH0717500B2 (ja) 1995-03-01
JPS62265220A (ja) 1987-11-18
HK63991A (en) 1991-08-23
NO173635C (no) 1994-01-12
KR870008581A (ko) 1987-10-19
PT84398B (pt) 1989-10-04
IE870569L (en) 1987-09-07
HUT47020A (en) 1989-01-30
EP0236822A3 (en) 1989-01-11
NZ219454A (en) 1989-04-26
DE3766984D1 (de) 1991-02-07

Similar Documents

Publication Publication Date Title
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
HK63991A (en) Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride
ES2056955T3 (es) Formulacion oral de buspirona y sales de la misma.
PT80221B (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
EG18555A (en) Process for preparing a substituted benzamides as anticonvulsant agents
DE3569107D1 (en) Compounds having an immunizing activity
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
PH27369A (en) Glutaric acid derivatives and preparations thereof
IL75166A (en) 2-substituted spiro(1,3-oxathiolane-5,3-quinuclidine)derivatives,their preparation and pharmaceutical compositions containing them and 3-hydroxy-3-mercaptomethylquinuclidine as intermidiate therefor
GR78670B (fr)
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.
MX9203581A (es) Composiciones farmaceuticas de indolinas 3,3-disubstituidas, para administracion nasal.